Type 2 diabetes mellitus (T2D) is a metabolic disease with inflammation as an important pathogenic background. However, the pattern of immune cell subsets and the cytokine profile associated with development of T2D are unclear. The objective of this study was to evaluate different components of the immune system in T2D patients' peripheral blood by quantifying the frequency of lymphocyte subsets and intracellular pro- and anti-inflammatory cytokine production by T cells. Clinical data and blood samples were collected from 22 men (51.6±6.3 years old) with T2D and 20 nonsmoking men (49.4±7.6 years old) who were matched for age and sex as control subjects. Glycated hemoglobin, high-sensitivity C-reactive protein concentrations, and the lipid profile were measured by a commercially available automated system. Frequencies of lymphocyte subsets in peripheral blood and intracellular production of interleukin (IL)-4, IL-10, IL-17, tumor necrosis factor-α, and interferon-γ cytokines by CD3+ T cells were assessed by flow cytometry. No differences were observed in the frequency of CD19+ B cells, CD3+CD8+ and CD3+CD4+ T cells, CD16+56+ NK cells, and CD4+CD25+Foxp3+ T regulatory cells in patients with T2D compared with controls. The numbers of IL-10- and IL-17-producing CD3+ T cells were significantly higher in patients with T2D than in controls (P<0.05). The frequency of interferon-γ-producing CD3+ T cells was positively correlated with body mass index (r=0.59; P=0.01). In conclusion, this study shows increased numbers of circulating IL-10- and IL-17-producing CD3+ T cells in patients with T2D, suggesting that these cytokines are involved in the immune pathology of this disease.

The objective of this study was to evaluate cardiorespiratory fitness and pulmonary function and the relationship with metabolic variables and C-reactive protein (CRP) plasma levels in individuals with diabetes mellitus (DM). Nineteen men with diabetes and 19 age- and gender-matched control subjects were studied. All individuals were given incremental cardiopulmonary exercise and pulmonary function tests. In the exercise test, maximal workload (158.3±22.3vs 135.1±25.2, P=0.005), peak heart rate (HRpeak: 149±12 vs 139±10, P=0.009), peak oxygen uptake (VO2peak: 24.2±3.2 vs18.9±2.8, P<0.001), and anaerobic threshold (VO2VT: 14.1±3.4 vs 12.2±2.2, P=0.04) were significantly lower in individuals with diabetes than in control subjects. Pulmonary function test parameters, blood pressure, lipid profile (triglycerides, HDL, LDL, and total cholesterol), and CRP plasma levels were not different in control subjects and individuals with DM. No correlations were observed between hemoglobin A1C (HbA1c), CRP and pulmonary function test and cardiopulmonary exercise test performance. In conclusion, the results demonstrate that nonsmoking individuals with DM have decreased cardiorespiratory fitness that is not correlated with resting pulmonary function parameters, HbA1c, and CRP plasma levels.

A nova espécie de ascomiceto Ophiodothella annonae (Ascomycetes: Phyllachoraceae) é descrita e ilustrada. O fungo causa manchas foliares em Annona squamosa. Folhas infectadas exibem lesões arredondadas de coloração marron-clara e com bordos enegrecidos, podendo cair prematuramente. O fungo apresenta ascósporos ligeiramente curvos, fusiformes, bigutulados e com uma concentração de citoplasma na região central. Esta é a primeira espécie de Ophiodothella encontrada em folhas de Annonaceae no Brasil.

A new species of Ophiodothella, O. annonae (Phyllachoraceae, Ascomycetes) is described and illustrated. The fungus causes brown lesions on leaves of Annonae squamosa, which can fall off prematurely, and is characterized by fusiform, slightly curved, biguttulate ascospores with a conspicuous central concentration of cytoplasm. This is the first species of Ophiodotella found on leaves of Annonaceae in Brazil.

O "Quantitative Buffy Coat" (QBC®) é um método direto e rápido de fluorescência, utilizado na identificação de parasitas hemáticos. Porque Leishmania chagasi circula no sangue, resolvemos testá-lo em leishmaniose visceral americana (LVA). Foram analisados medula óssea (MO) e sangue periférico (SP) de 49 pessoas e SP de 31 cães. O QBC® foi positivo na MO de 11/11 pacientes com LVA e em 1/6 com outras doenças. Foram identificados amastigotas no SP de 18/22 pacientes com LVA e em nenhum de 10 sem LVA. O teste foi positivo em 30 dos 31 cães sororreagentes e em 28/28 cães que tiveram Leishmania identificada em outros tecidos. O QBC® é um método promissor para o diagnóstico de LVA humana, e possivelmente para exame do SP de pacientes com LVA/AIDS, para controle de cura ou para identificação de portadores assintomáticos. Devido à facilidade da coleta, execução e rapidez, deveria ser avaliado para programas de controle de reservatórios.

"Quantitative Buffy Coat" (QBC®) is a direct and fast fluorescent method used for the identification of blood parasites. Since Leishmania chagasi circulates in blood, we decided to test it in American visceral leishmaniasis (AVL). Bone marrow (BM) and peripheral blood (PB) of 49 persons and PB of 31 dogs were analyzed. QBC® was positive in BM of 11/11 patients with AVL and in 1/6 patients with other diseases. Amastigotes were identified in PB of 18/22 patients with AVL and in none without AVL. The test was positive in 30 out of the 31 seropositive dogs and in 28/28 dogs with Leishmania identified in other tissues. QBC® is a promising method for diagnosis of human AVL, and possibly for the exam of PB of patients with AVL/AIDS, for the control of the cure and for the identification of asymptomatic carriers. Because it is fast and easy to collect and execute, QBC® should be evaluated for programs of reservoir control.